Furthermore, a recent study suggested that phosphotyrosine 1 phosphatase (PTP1B) and protein phosphatase 2 (PP2A), carried by EVs from insulin-resistant individuals, may serve as potential therapeutic targets against insulin resistance in adipose tissue and liver, as well as for preventing the development of obesity [99]. Here, PTPN1 is linked to Insulin resistance.